ArticleFrontiers in neuroscience2016

Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists.

Jorge Navarro-Dorado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.